Bean amylase inhibitor and other carbohydrate absorption blockers: Effects on diabesity and general health

Journal of the American College of Nutrition

Volumn 28, Issue 3, 2009, Pages 266-276

  Preuss, Harry G ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alpha glucosidase inhibitors; Amylase inhibitors; Bean extract; Carbohydrate blockers; L arabinose

Indexed keywords

AMYLASE; AMYLASE INHIBITOR; ARABINOSE; CARBOHYDRATE; CHROMIUM DERIVATIVE; GLUCOSE; GYMNEMA SYLVESTRE EXTRACT; HIBISCUS EXTRACT; INSULIN; NIACIN BOUND CHROMIUM; PHASE 2; PHLORIZIN; PLANT EXTRACT; RESISTANT STARCH; SATURATED FATTY ACID; STARCH; UNCLASSIFIED DRUG; WHITE KIDNEY BEAN EXTRACT;

ABSENCE OF SIDE EFFECTS; AGING; ATHEROSCLEROSIS; BODY FAT; CALORIC RESTRICTION; CARBOHYDRATE ABSORPTION; CARBOHYDRATE DIET; CARBOHYDRATE INTAKE; CARBOHYDRATE TRANSPORT; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIET; DIETARY FIBER; DIGESTION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCEMIC INDEX; HIBISCUS; HIP; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID STORAGE; LOW CARBOHYDRATE DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHASEOLUS VULGARIS; PUBLIC HEALTH PROBLEM; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; TENSION HEADACHE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ABSORPTION; AMYLASES; DIABETES MELLITUS, TYPE 2; DIETARY CARBOHYDRATES; DIETARY SUPPLEMENTS; HUMANS; INSULIN RESISTANCE; INTESTINAL ABSORPTION; OBESITY; PHASEOLUS; VEGETABLE PROTEINS;

ANIMALIA; PHASEOLUS VULGARIS;

EID: 77951582999     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2009.10719781     Document Type: Article

References (136)

1. WHO: “Obesity: Preventing and Managing the Global Epidemic,” Report of WHO Consultation on Obesity, Technical Report Series No 894. Geneva: World Health Organization, pp i-xii, 1-253, 2000.
2. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 22:1414-1431, 1998.
3. Ford ES, Mokdad AH, Giles WH, Galuska DA, Serdula MK: Geographic variatioas in the prevalence of obesity, diabetes, and obesity-related behaviors. Obes Res 13:118-122, 2005.
4. Yaturu S, Jain SK: Obesity and type 2 diabetes. In Bagchi, D, Preuss HG (eds): “Obesity. Epidmiology, Pathophysiology, and Prevention.” Boca Raton, FL: CRC Press, pp 139-154, 2007.
5. Bray GA: The epidemic of obesity and changes in food intake: the Fluoride Hypothesis. Physiol Behav 82:115-121, 2004.
6. Ohlson LO, Larsson B, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L, Bjorntorp P, Tibblin G: The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 34:1055-1058, 1985.
7. Kaye SA, Folsomn AR, Sprafka JM, Prineas RJ, Wallace RB: Increased incidence of diabetes mellitus in relation to abdominal adiposity in older women. J Clin Epidemiol 44:329-334, 1991.
8. Lundgren H, Bengtsson C, Blohme G, Lapidus L, Sjostrom L: Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: results from a prospective population study in Gothenburg, Sweden. Int J Obes 13:413-423, 1989.
9. Prevalence of overweight and obesity among adults with diagnosed diabetes—United States, 1988-1994 and 1999-2002. MMWR 53:1066-1068, 2004.
10. Gardner DC, Kiazand A, Alhassan S, Kim S, Stafford RS, Balise RR, Kraemer HC, King AC: Comparison of the Atkias, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women; the A to Z weight loss study: a randomized trial. JAMA 297:969-977, 2007.
11. Iacobellis G, Ribaudo MC, Leto G, Zappaterreno A, Vecci E, Di Mario U, Leonetti F: Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity. Obes Res 10:767-763, 2002.
12. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS: Obesity and the risk of heart failure. N Eng J Med 347:305-313, 2002.
13. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, Ezzati M: The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med Epub Apr 28, 2009.
14. Popkin BM, Paeratakul S, Zhai F, Keyou G: A review of dietary and environmental correlates of obesity with emphasis on developing countries. Obes Res 3:145S-153S, 1995.
15. WHO Consultation on Obesity. Geneva: WHO, 1997.
16. Turconi G, Cena H: Epidemiology of obesity. In Bagchi D, Preuss HG (eds): “Obesity. Epidmiology, Pathophysiology, and Prevention.” Boca Raton, FL: CRC Press, pp 3-19, 2007.
17. Pain GC: Epidemiology of obesity: a global burden for the new millenium. In Bagchi D, Preuss HG (eds): “Obesity. Epidmiology, Pathophysiology, and Prevention.” Boca Raton, FL: CRC Press, pp 21-29, 2007.
18. Ogden CL, Flegal KM, Carroll MD, Johnson CL: Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 288:1728-1732, 2002.
19. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295:1549-1555, 2006.
20. Arsenault BJ, Cartier A, Cote M, Lemieux I, Tremblay A, Bouchard C, Perusse L, Despies JP: Body composition, cardiorespiratory fitness, and low-grade inflammation in middle-aged men and women. Am J Cardiol 104:240-246, 2009.
21. Lee CG, Carr MC, Murdoch SJ, Mitchell E, Woods NF, Wener MH, Chandler WL, Boyko EJ, Brunzell JD: Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol 94:1104-1110, 2009.
22. Mittelman SD, Van Citters GW, Kirkman EL, Bergman RN: Extreme insulin resistance of the central adipose depot in vivo. Diabetes 51:755-761, 2002.
23. Ohman MK, Wright AP, Wickenheiser KJ, Luo W, Eitzman DT: Visceral adipose tissue and atherosclerosis. Curr Vase Pharmacol 7:169-179, 2009.
24. Lowenstein FW: Major nutritional findings from the First Health and Nutrition Examination Survey in the United States of America, 1971-1974. Bibl Nutr Dieta 30:1-16, 1981.
25. Nelson LH, Tucker LA: Diet composition related to body fat in a multivariate study of 203 men. J Am Diet Assoc 96:771-777, 1996.
26. Dorfman SE, Laurent D, Gounarides JS, Li X, Mullarkey TL, Rocheford EC, Sari-Sarraf F, Hirsch EA, Hughes TE, Commerford SR: Metabolic implicatioas of dietary trans-fatty acids. Obesity 17:1200-1207, 2009.
27. Enig MG: Know Your Fats: “The Complete Primer for Understanding the Nutrition of Fats, Oils, and Cholesterol.” Bethesda Press, May 2000.
28. Harper A, Astrup A: Can we advise our obese patients to follow the Atkins diet? Obes Rev 5:93-94, 2004.
29. Ornish D: Was Dr Atkins right? J Am Diet Assoc 104:537-542, 2004.
30. Macdonald I: Carbohydrates. In Shils ME, Olson JA, Shike M. (eds): “Modern Nutrition in Health and Disease.” Philadelphia: Lea & Febiger, pp 36-46, 1994.
31. Sanders LM, Lupton JR: Carbohydrates: In Bowman BA, Russell RM (eds): “Present Knowledge in Nutrition,” 8th ed. Washington DC: ILSI Press, pp 78-88, 2001.
32. Bell SJ, Van Ausdal W, Grochoski G: Appetite, body weight, health implications of a low-glycemic-load diet. In Bagchi D, Preuss HG (eds): “Obesity. Epidmiology, Pathophysiology, and Prevention.” Boca Raton, FL: CRC Press, pp 245-263, 2007.
33. Preuss HG, Bagchi D: Nutritional therapy of impaired glucose tolerance and diabetes mellitus. In Bronner F (ed): “Nutritional Aspects and Clinical Management of Chronic Disorders and Diseases.” Boca Raton FL: CRC Press, pp 69-91, 2002.
34. Bell SJ, Scars B: Low-glycemic-load diets: impact on obesity and chronic diseases. CRC Crit Rev Food Sei Nutr 43:357-377, 2003.
35. Bell SJ, Wolbers J, Casterton W: Use of a low-glycemic load diet to promote weight loss. Nutra World 8:50-51, 2005.
36. Crawford V, Scheckenbach R, Preuss HG: Effects of niacin-bound chromium supplementation on body composition of overweight African-American women. Diabetes Obes Metab 1:331-337, 1999.
37. Anderson RA: Chromium as an essential nutrient for humans. Reg Toxicol Pharmacol 26:S35-S41, 1997.
38. Anderson RA: Nutritional factors influencing the glucose/insulin system: chromium. J Amer Coll Nutr 16:404-410, 1997.
39. Preuss HG: Effects of glucose/iasulin perturbations on aging and chronic disorders of aging: the evidence. J Am Coll Nutr 16:397-403, 1997.
40. DeFronzo RA, Ferinimmi E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipi-demia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991.
41. Reaven G: The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol. Metab Clin North Am 33:283-303, 2004.
42. Szanto S, Yudkin J: The effect of dietary sucrose on blood lipids, serum insulin, platelet adhesiveness, and body weight in human volunteers. Postgrad Med J 45:602-607, 1969.
43. Yudkin J: The low carbohydrate diet in the treatment of obesity. Postgrad Med 51:151-154, 1972.
44. Reiser S, Handler HB, Gardner LB, Hallfrisch JG, Michaelis OE, Prather ES: Isocaloric exchange of dietary starch and sucrose in humans. II. Effect on fasting blodd iasulin, glucose, and glucagon and on insulin and glucose response to a sucrose load. Am J Clin Nutr 32:2206-2216, 1979.
45. Yudkin J: Sugar and obesity. Lancet 2:794, 1983.
46. Yudkin J: Sucrose, coronary heart disease, diabetes, and obesity. Do hormones provide a link? Am Heart J 115:493-498, 1988.
47. No author Ls the Atkins diet on to something? No, it’s not a healthy way to eat. But the high-protein, low-carbohydrate diet may hold a few important lessons about weight loss and healthy eating. Harvard Health Lett 28:1-2, 2003.
48. Wolf BW, Oolever TM, Lai CS, Bolognesi C, Radmard R, Maharry KS, Garleb KA, Hertzler SR, Firkins JL: Effects of a beverage containing an enzymatically induced-viscosity dietary fiber, with or without fructose, on the postprandial glycemic response to a high glycemic index food in humans. Eur J Clin Nutr 57:1120-1127, 2003.
49. Harrington S: The role of sugar-sweetened beverage consumption in adolescent obesity: a review of the literature. J Sch Nurs 24:3-12, 2008.
50. Dubois L, Farmer A, Girard M, Peterson K: Regular sugar-sweetened beverage consumption between meals increases risk of overweight among preschool-aged children. J Am Diet Assoc 107:934-935, 2007.
51. Duffey KJ, Popkin BM: Shifts in patterns and consumption of beverages between 1965 and 2002. Obesity 15:2739-2747, 2007.
52. Reaven GM, Chen N, Hollenbeck C, Chen YDI: Effect of age on glucose tolerance and glucose uptake in healthy individuals. J Am Ger Soc 37:735-740, 1989.
53. Broughton DL, Taylor RL: Review: deterioration of glucose tolerance with age: the role of insulin resistance. Age Aging 20:221-225, 1991.
54. Shimokata H, Muller DC, Reg JL, Sorkin J, Ziemba AW, Andres R: Age as independent determinant of glucose tolerance. Diabetes 40:44-51, 1991.
55. DeFronzo R: Glucose intolerance and aging. Diabetes Care 4:493-501, 1981.
56. Lee K: Usefulness of the metabolic syndrome criteria as predictors of insulin resistance among obese Korean women. Public Health Nutr 26:1-6, 2009.
57. Wada H, Satoh N, Kitaoka S, Ono K, Morimoto T, Kawamura T, Nakano T, Fujita M, Kita T, Shimatsu A, Hasegawa K: Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance. Atherosclerosis Jul 30, 2009 [Epub ahead of print].
58. Preuss HG, Bagchi D, Clouatre D: Insulin resistance; a factor in aging. In Ghen MJ, Corso N, Joiner-Bey H, Klatz R, Dratz A (eds): “The Advanced Guide to Longevity Medicine.” Landrum SC: Ghen, pp 239-250, 2001.
59. Masoro EJ: Assessment of nutritional components in prolongation of life and health by diet. Proc Soc Exper Biol Med 193:31-34, 1990.
60. Masoro EJ: Nutrition as a modulator of the aging process. Physiologist. 27:98-101, 1984.
61. Hopkin K: Aging in focus. Caloric restriction may put the brakes on aging. J NEH Research 7:47-50, 1995.
62. Yudkin JS: Sugar and disease. Nature 239:197-199, 1972.
63. Yudkin JS: Patterns and trends in carbohydrate consumption and their relation to disease. Proc Nutr Soc 23:149-162, 1964.
64. Yudkin JS: Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Metab Disord 27:S25-S28, 2003.
65. Yudkin JS: Insulin resistance and the metabolic syndrome -the pitfalls of epidemiology. Diabetologia 50:1576-1586, 2007.
66. Masoro EJ, McCarter RJM, Katz MS, McMahan CA: Dietary restriction alters characteristics of glucose fuel use. J Gerontol 47:B202-B208, 1992.
67. Cerulli J, Lomaestro BM, Malone M: Update on the pharmacotherapy of obesity. Ann Pharmacol 32:88-102, 1998.
68. Carek PJ, Dickerson LM. Current concepts in the pharmacological management of obesity. Drugs 57:883-904, 1999.
69. FDA: Early communications about ongoing safety review Orlistat (marketed as Alii and Xenical). 8/24/09. http://www.fda.gov/Drugs/ DrugSafety/PostmarketDrugSafetylnformationforPatientsand Proviers/DrugSafetylnformationforHeathcareProfessionals/ucm 179166.htm.
70. Pawlak DB, Kushner JA, Ludwig DS: Effects of dietary glycaemic index on adiposity, glucose homeostasis, and plasma lipids in animals. Lancet 364:778-785 2004.
71. Brehm BJ, Seeley RJ, Daniels SR, D’Allessio DA: A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Fam Pract 52:515-516, 2003.
72. Meckling KA, Gauthier M, Grubb R, Sanford J: Effects of a hypocaloric, low carbohydrate diet on weight loss, blood lipids, blood pressure, glucose tolerance, and body composition in free-living overweight women. Cañad J Physiol Pharmacol 80:1095-1105, 2002.
73. McAuley KA, Hopkins CM, Smith KJ, McLay RT, Williams SM, Taylor RW, Mann JI: Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women. Diabetologia 48:8-16, 2005.
74. Thomas DE, Elliot EJ, Baur L: Low glycaemic loads for overweight and obesity. Cochrane Database Syst Rev Jul 18;CD005105.
75. Ganji V, Kies CV: Psyllium husk fiber supplementation to soybean and coconut oil diets of humans: effect of fat digestibility and faecal fatty acid excretion. Eur J Clin Nutr 48:595-597, 1994.
76. Wadstein J, Thom E, Heldman E, Gudmunsson S, Lilja B: Biopolymer LI 12, a chitosan with fat binding properties and potential as a weight reducing agent. In Muzzarelli RAA (ed): “Chitosan Per Os; From Dietary Supplement to Drug Carrier.” Grottammare, Italy: Atec, pp 65-76, 2000.
77. Preuss HG, Kaats GR: Chitosan as a dietary supplement for weight loss. A review. Curr Nutr Rev 2:297-311, 2006.
78. Preuss HG, Gottlieb B: Lower your carbs - without a low-carb diet. In “The Natural Fat-Loss Pharmacy.” New York: Broadway Books, pp 105-124, 2007.
79. Fukagawa NK, Anderson JW, Hageman G, Young VR, Ninaker KL: High-carbohydrate, high-fiber diets increase peripheral insulin sensitivity in healthy young and old adults. Am J Clin Nutr 52:524-528, 1990.
80. Jenkins DJ, Kendall CW, Marchie A, Jenkias AL, Augustin LS, Ludwig DS, Barnard ND, Anderson JW: Type 2 diabetes and the vegetarian diet Am J Clin Nutr. 78(3 Suppl):610S-616S, 2003.
81. Zein M, Areas J, Knapka J, Gleim G, DiPette D, Holland B, Preuss HG: Influence of oat bran on sucrose-induced blood pressure elevations in SHR. Life Sei 47:1121-1128, 1990.
82. Preuss HG, Gondal JA, Bustos E, Bushehri N, Lieberman S, Bryden NA, Polansky MM, Anderson RA: Effect of chromium and guar on sugar-induced hyperteasion in rats. Clin Neph 44:170-177, 1995.
83. Udani J, Hardy M, Kavoussi B: Dietary supplement carbohydrate digestion inhibitors: A review of the literature. In Bagchi D, Preuss HG (eds): “Obesity. Epidmiology, Pathophysiology, and Prevention.” Boca Raton, FL: CRC Press, pp 279-298, 2007.
84. Meiss DE: Phaseolus vulgaris and alpha amylase inhibition. In Bagchi D, Preuss HG (eds): “Obesity. Epidmiology, Pathophysiology, and Prevention.” Boca Raton, FL: CRC Press, pp 423-432, 2007.
85. Brudnak MA: Weight-loss drugs and supplements: arc there safer alternatives? Med Hypotheses 58:28-33, 2002.
86. Guyton AC, Hall JE: ‘Textbook of Medical Physiology,” 9th ed. Philadelphia: WB Saunders, Chap 2, 1996.
87. Andoh A, Tsujikawa T, Fujiyama Y : Role of dietary fiber and short chain fatty acids in the colon. Curr Pharm Des 9:347-358,2003.
88. Higgins JA, Higbee DR, Donahoo WT, Brown IL, Bell ML, Bessesen DH: Resistant starch consumption promotes lipid oxidation. Nutr Metabolism 1:8, 2004.
89. Keenan MJ, Zhou J, McCutcheon KL, Raggio AM, Bateman HG, Todd E, Jones CK, Tulley RT, Melton S, Martin RJ, Hegsted M: Effects of resistant starch, a non digestible fermentable fiber, on reducing body fat. Obesity 14:1523-1534, 2006.
90. Grabitske HA, Slavin JL: Low-digestible carbohydrates in practice. J Am Diet Assoc 108:1677-1681, 2008.
91. Obiro WC, Zhang T, Jiang B: The nutraceutical role of the Phasoleus vulgaris a-amylase inhibitor. Br J Nutr 100:1-12, 2008.
92. Marshal JJ, Lauda CM: Purification and properties of phaseola-min, an inhibitor of alpha-amylase from the kidney bean, Phaseolus vulgaris. J Bio Chem 250:8030-8037, 1975.
93. Lajolo FM, Filho FF, Menezes EW: Amylase inhibitors in Phaseolus vulgaris beans. Food Technol. Sept: 119-121, 1991.
94. Nakaguchi T, Arakawa T, Philo JS, Wen J, Ishimoto M, Yamaguchi H: Structural characterization of an alpha-amylase inhibitor from a wild common bean (Phaseolus vulgaris): insight into the common structural features of leguminous alpha-amylase inhibitors. J Biochem. 121:350-354, 2004.
95. Payan F: Structural basis for the inhibition of mammalian and insect alpha-amylase by plant protein inhibitors. Biochim Biophy Acta 1696:171-180, 2004.
96. Santimone M, Koukiekolo R, Moreau Y, Le Berre V, Rouge P, Marchis-Mouren G, Desseaux V: Porcine pancreatic alpha-amylase inhibition by the kidney bean (Phaseolus vulgaris) inhibitor (alpha-All) and structural changes in the alpha-amylase complex. Biochim Biophy Acta 16%: 181-190, 2004.
97. Bo-Linn GW, Santa Ana CA, Morawski SG, Fordtran JS: Starch blockers - their effect on calorie absorption from a high-starch meal. New Eng J Med 307:1413-1416, 1982.
98. Hollenbeck CB, Coulston AM Quan R, Becker TR, Vreman HJ, Stevenson DK, Reaven GM: Effects of a commercial starch blocker preparation on carbohydrate digestion and absorption: in vivo and in vitro studies. Am J Clin Nutr 38:498-503, 1983.
99. Garrow JS, Scott PF, Heels S, Nair KS, Halliday D: A study or ‘starch blockers” in many using 13C-enriched starch as a tracer. Hum Nutr Clin Nutr. 37:301-305, 1983.
100. Carlson GL, Li BU, Bass P, Olsen WA: A bean alpha-amylase inhibitor formulation (starch blocker) is ineffective in man. Science 219:393-395, 1983.
101. Layer P, Carlson GL, DiMagno EP: Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans, Gastroenterology 88:1895-1902, 1985.
102. Layer P, Ziasmeister AR, DiMagno EP: Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology 88:1895-1902, 1985.
103. Layer P, Rizza RA, Zinsmeister AR, Carlson GL, DiMagno EP: Effect of a purified amylase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes mellitus. Mayo Clin Proc 61:442-447, 1986.
104. Bmgge WR, Rosenfeld MS: Impairment of starch absorption by a potent amylase inhibitor. Am J Gastroenterol 82:718-722, 1987.
105. Boivin M, Ziasmeister AR, Go VL, DiMagno EP: Effect of a purified amylase inhibitor on carbohydrate metabolism after a mixed meal in healthy humans. May Clin Proc 62:249-255, 1987.
106. Jain NK, Boivin M, Ziasmeister AR, Brown ML, Malagelada JE, DiMagno EP: Effect of ileal perfusion of carbohydrates and amylase inhibitor on gastrointestinal hormones and emptying. Gastroenterology 96:377-387, 1989.
107. Boivin M, Flourie B, Rizza RA, Go VL, DiMagno EP: Gastrointestinal and metabolic effects of amylase inhibition in diabetics. Gastroenterology 94:387-394, 1988.
108. Tormo MA, Gil-Exojo I, Romero de Tejada A, Campillo JE: Hypoglycemic and anorexigenic activities of an alpha-amylase inhibitor from white kidney beans (Phaseolus vulgaris) in Wistar rats. Br J Nutr 92:785-790, 2004.
109. Deglaire A, Moughan PJ, Bos C, Tome D: Commercial Phaesolus vulgaris extract (starch stopper) increases ileal endogenous amino acid and crude protein losses in the growing rat. J Agrie Food Chem 54:5197-5202, 2006.
110. Pneuss HG, Echard B, Talpur N, Talpur F, Stohs S: Inhibition of starch and sucrose gastrointestinal absorption in rats by various dietary supplements alone and combined. Acute studies Int J Med Sei 4:196-202, 2007.
111. Preuss HG, Echard B, Talpur N, Talpur F, Stohs S: Inhibition of starch and sucrose gastrointestinal absorption in rats by various dietary supplements alone and combined. Subchronic studies. Int J Med Sei 4:209-215, 2007.
112. Vinson JA, Al Kharrat H, Shuta D: Investigation of an amylase inhibitor on human glucose absorption after starch consumption. Open Nutraceutical J 2:88-91, 2009.
113. Thom E: A randomized, double-blind, placebo-controlled trial of a new weight-reducing agent of natural origin. J Int Med Res 28:229-233, 2000.
114. Celleno L, Perricone NV, Preass HG: Effect of a dietary supplement containing standardized Phaseolus vulgaris extract on the body composition of overweight men and women. Int J Med Sei 4:45-52, 2007.
115. Udani J, Hardy M, Madsen DC: Blocking carbohydrate absorption and weight loss: a clinical trial using Phase 2 brand proprietary fractionated white bean extract. Altem Med Rev 9:63-69, 2004.
116. Udani J, Singh BB: Blocking carbohydrate absorption and weight loss: a clinical trial using a proprietary fractionated white bean extract. Altern Ther Health Med 13:32-37, 2007.
117. Food and Agricultural Organization/World Health Organization Expert Coasultation on Carbohydrates in Human Nutrition. Carbohydrates in Human Nutrition: A Report of a Joint F AO WHO Expert Consultation. F AO Food and Nutrition Paper no. 66. Rome: FAO, 1998.
118. Smith T, Brown JC, Livesy G: Energy balance and thermogenesis in rats consuming non starch polysaccharides of various fermentabilities. Am J Clin 68:802-819, 1998.
119. Koike T, Koizumi Y, Tang L, Takahara K, Saitou Y: The antiobesity effect and the safety of taking “Phaseolamin™ 1600 diet”. J New Rem Clin 54:1-16, 2005.
120. Wu X, Xu X, Shen J, Preuss HG: Enhanced weight loss from a dietary supplement containing standardized Phaseolus vulgaris extract in overweight men and women (Submitted for publication).
121. Chokshi D: Toxicity studies of Blokal, a dietary supplement containing Phase 2 starch neutralizer (Phase 2), standardized extract of the common white kidney bean (Phaseolus vulgaris). Int J Toxicol 25:361-371, 2006.
122. Chokshi D: Subchronic oral toxicity of a standardized white kidney bean (Phaseolus vulgaris) extract in rats. Food Chem / Toxicol 45:32-40, 2007.
123. Hansawasdi C, Kawabata J, Kasai T: Alpha-amylase inhibitors from roselle (Hibiscus sahdariffa Linn.) tea. Biosci Biotechnol Biochem 64:1041-1043, 2000.
124. Hansawadi C, Kawabata J, Kasai T: Hibiscus acid as an inhibitor of starch digestion in the Caco-2 cell model system. Biosci Biotechnol Biochem 65:2087-2089, 2001.
125. Sachdewa A, Khemani LD: Effects of Hibiscus rosa sinensis Linn, ethanol flower extract on blood glucose and lipid profile in streptozotocin induced diabetes in rats. J Ethnopharmacol, 89, 61-66, 2003.
126. Lankisch M, Layer P, Rizza RA, DiMagno EP: Acute postprandial gastrointestinal and metabolic effects of wheat amylase inhibitor (WAI) in normal, obese, and diabetic humans. Pancreas 17:176-181, 1998.
127. Seri K, Sanai K, Matsuo N, Kawakubo K, Xue C, Inoue S: L-arabinose selectively inhibits intestinal sucrase in an uncompetitive manner and suppresses glycemic respoase after sucrose ingestion in animals. Metabolism 45:1368-1374, 1996.
128. Osaki S, Kimura T, Sugimoto T, Hizukuri S, Iritani N: L-arabinose feeding prcvents increases due to dietary sucrose in lipogenic enzymes and triacylglycerol levels in rats. J Nutr 131:796-799, 2001.
129. Inoue S, Sanai K, Seri K. Effect of L-arabinose on blood glucose level after ingestion of sucrose-containing food in humans. J Jpn Soc Nutr Food Sei 53:243-247, 2000.
130. Yoshikawa M, Muarakami T, Kadoya M, Li Y, Murakami N, Yamahara J, Matsuda H: The inhibitors of glucose absorption from the leaves of Gymnema sylvestre R. BR. (Asclepiadaceae): structures of gymnemosides a and b. Chem Pharm Bull 45:1671-1676, 1997.
131. Shimizu K, lino A, Nakajima J, Tanaka K, Nakajyo S, Urakawa N, Atsuchi M, Wada T, Yamashita C: Suppression of glucose absorption by some fractions extracted from Gymnema sylvestre leaves. J Vet Med Sei 59:245-251, 1997.
132. Hirsh AJ, Yao SY, Young JD, Cheeseman Cl: Inhibition of glucose absorption in the rat jejunum: a novel action of alpha-D-glucosidase inhibitors. Gastroenterology 113:205-211, 1997.
133. Kwon O, Eck P, Chen S, Corpe CP, Lee J-H, Kruhlak M, Levine M: Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. The FASEB J 21:366-377, 2007.
134. Sugimoto K, Suzuki J, Nakagawa K, Hayachi S, Enomoto T, Fujita T, Yamaji R, Ryoichi Inui H, Nakano Y: Eucalyptus leaf extract inhibits intestinal fructose absorption, and suppresses adiposity due to dietary sucrose in rats. Br J Nutr 93:957-963, 2005.
135. Burkitt DP: Western diseases and their emergence related to diet. S AfrMed J 61:1013-1015, 1982.
136. Burkitt DP, Trowell HC: Nutritional intake, adiposity, and diabetes. Br Med J 1:1083-1084, 1979.